FDA.reportPublic FDA data

toripalimab-tpzi 240 MG in 6 ML Injection

RxCUI
2669413
RxNorm name
toripalimab-tpzi 240 MG in 6 ML Injection
Display name
toripalimab-tpzi 240 MG in 6 ML Injection
Full name
toripalimab-tpzi 240 MG in 6 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761240Loqtorzitoripalimab-tpzi351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LOQTORZITORIPALIMAB-TPZICoherus Oncology, Inc.82e7921a-1e84-4988-9799-0ad7d19b2a752026-07-23Warnings, Adverse reactionsExact identifier
rxcui: 2669413

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
82e7921a-1e84-4988-9799-0ad7d19b2a75toripalimab-tpzi 240 MG in 6 ML Injection [PSN] · 6 ML toripalimab-tpzi 40 MG/ML Injection [SCD] · toripalimab-tpzi 240 MG per 6 ML Injection [SY]38These highlights do not include all the information needed to use LOQTORZI safely and effectively. See full prescribing information for LOQTORZI. LOQTORZI ® (toripalimab-tpzi) injection, for intravenous use Initial U.S. Approval: 202320260105